Regeneron Pharmaceuticals Dividend
Regeneron Pharmaceuticals Dividend history 5 years & estimates 2026
Dividend Analysis of the Regeneron Pharmaceuticals Stock
|
Criteria / Value
Criteria
Value
|
Grade | |
|---|---|---|
| 0/3 | ||
| 0/3 | ||
|
Payout 3Y
0.00%
|
0/3 | |
|
Continuity 10Y
1 Year
|
0/3 | |
|
Growth 5Y
N/A
|
0/3 | |
| No top scorer |
Total: 0/15
|
|
When does Regeneron Pharmaceuticals pay a dividend?
Regeneron Pharmaceuticals pays the next dividend on Dec 05 2025 (payday). The ex-day is on Nov 20 2025. The Regeneron Pharmaceuticals stock dividend is paid 4 times a year. In order to receive a dividend, you should generally own the Regeneron Pharmaceuticals stock before the ex-dividend date. The Dividend Calendar shows that the last ex-day dates were February, May, August and November . Dividends from Regeneron Pharmaceuticals are distributed via March, June, September and December.
| Year | Dividend | Ex-day & Payday |
Frequency | |
|---|---|---|---|---|
| Fiscal Year | Dividend per Share | Ex-Day | Payday | Payment frequency |
| 2025 |
$0.88
Forecast
$0.88
Forecast
|
Nov 20 2025
Nov 20 2025
Dec 05 2025
Nov 20 25
Dec 05 25 |
Dec 05 2025 |
quarterly
quarterly
|
| 2025 |
$0.88
$0.88
|
Aug 18 2025
Aug 18 2025
Sep 03 2025
Aug 18 25
Sep 03 25 |
Sep 03 2025 |
quarterly
quarterly
|
| 2025 |
$0.88
$0.88
|
May 20 2025
May 20 2025
Jun 06 2025
May 20 25
Jun 06 25 |
Jun 06 2025 |
quarterly
quarterly
|
| 2025 |
$0.88
$0.88
|
Feb 20 2025
Feb 20 2025
Mar 20 2025
Feb 20 25
Mar 20 25 |
Mar 20 2025 |
-
-
|
How much dividend does Regeneron Pharmaceuticals pay?
Regeneron Pharmaceuticals most recently paid a dividend of $0.88. Regeneron Pharmaceuticals paid a Dividend of $3.52 Per Share in the financial year 2025. With a stock price of $651.80 at Oct 31 2025, the current dividend yield is 0.54% (calculation: $3.52 / $651.80 = 0.54%). No special dividend was paid.
What is the Regeneron Pharmaceuticals Dividend Yield and payout ratio?
The average Regeneron Pharmaceuticals dividend yield over the last 5 years is 0.10% and the average over the last 10 years is 0.06%.
The payout ratio of Regeneron Pharmaceuticals in relation to the last financial year is 0.00%. The payout ratio smoothed over 3 years is 0.00%. The calculation is based on the sum of all dividend payments divided by the cumulative earnings per share(EPS).
| Metric | Regeneron Pharmaceuticals |
|---|---|
| Current dividend yield | 0.54% |
| Dividend Yield 5Y | 0.10% |
| Dividend Yield 10Y | 0.06% |
| Payout 1Y | 0.00% |
| Payout 3Y | 0.00% |
Is the Regeneron Pharmaceuticals dividend safe? Continuity & Dividend Growth
Is the Regeneron Pharmaceuticals dividend safe?
Regeneron Pharmaceuticals has been paying a dividend since 1 and has not reduced the dividend since 1 (dividend continuity). As a result, the dividend was recently increased 1-times.
The Dividend Growth in relation to the previous financial year amounts to 100.00%.
| Metric | Regeneron Pharmaceuticals |
|---|---|
| Increased | 1 Year |
| Continuity | 1 Year |
| Paid | 1 Year |
| Growth 1Y | 100.00% |
Continuity
Regeneron Pharmaceuticals has been paying a dividend since 1 and has not reduced the dividend since 1 (dividend continuity). As a result, the dividend was recently increased 1-times.
Dividend Growth
The Dividend Growth in relation to the previous financial year amounts to 100.00%.
Regeneron Pharmaceuticals Stock Forecast 2025
On the stock exchange, the Regeneron Pharmaceuticals stock (ISIN: US75886F1075) is not traded as a top scorer in October 2025 according to the dividend strategy.
The stock price of Regeneron Pharmaceuticals -8.50% has fallen since the beginning of the year 2025. However, the return generated in the past says nothing about the future return. You can find the Regeneron Pharmaceuticals stock price in real time at the top of the page.
Regeneron Pharmaceuticals (symbol: REGN) is valued at a Price / Earnings Ratio (P/E ratio) of 15.88 and a price/sales ratio (P/S ratio) of 4.82 valued. Based on analyst estimates, the Regeneron Pharmaceuticals stock forecast 2025 of the current financial year corresponds to a valuation of 16.37 according to P/E ratio and 4.84 according to P/S.
| Metric | Regeneron Pharmaceuticals |
|---|---|
| Dividend Score | 0/15 |
| Performance 2025 |
8.50%
|
| P/E TTM | 15.88 |
| P/S TTM | 4.82 |
| P/E forward | 16.37 |
| P/S forward | 4.84 |
Regeneron Pharmaceuticals (symbol: REGN) is valued at a Price / Earnings Ratio (P/E ratio) of 15.88 and a price/sales ratio (P/S ratio) of 4.82 valued. Based on analyst estimates, the Regeneron Pharmaceuticals stock forecast 2025 of the current financial year corresponds to a valuation of 16.37 according to P/E ratio and 4.84 according to P/S.
Discover more Dividend Stocks
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
